{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:57:55Z","timestamp":1782845875478,"version":"3.54.5"},"reference-count":52,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["FPU18\/00490"],"award-info":[{"award-number":["FPU18\/00490"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatment in therapeutic communities. Method: The data of 2458 inpatients were used. Clinical information was obtained from electronic medical records. Reliability of diagnosis was checked and revealed a mean kappa value of 0.88. Results: Of the sample, 41.8% were discharged after achieving the therapeutic objectives. Patients diagnosed with Cluster B personality disorders were found to have a higher risk of dropping out of treatment (HR = 1.320; z = 2.61; p = 0.009). Conclusions: Personality traits exhibited by Cluster B patients can interfere with treatment in therapeutic communities. There is a need to develop specific interventions for these inpatient groups, which could be implemented in therapeutic communities.<\/jats:p>","DOI":"10.3390\/jcm10122572","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:31:39Z","timestamp":1623331899000},"page":"2572","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-8701","authenticated-orcid":false,"given":"Daniel","family":"Dacosta-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain"},{"name":"Research Center for Natural Resources, Health and Environment, University of Huelva, 21071 Huelva, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-4683","authenticated-orcid":false,"given":"Carmen","family":"D\u00edaz-Batanero","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain"},{"name":"Research Center for Natural Resources, Health and Environment, University of Huelva, 21071 Huelva, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fermin","family":"Fernandez-Calderon","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain"},{"name":"Research Center for Natural Resources, Health and Environment, University of Huelva, 21071 Huelva, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-6563","authenticated-orcid":false,"given":"\u00d3scar M.","family":"Lozano","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Psychology, University of Huelva, 21071 Huelva, Spain"},{"name":"Research Center for Natural Resources, Health and Environment, University of Huelva, 21071 Huelva, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"ref_1","unstructured":"Torrens, M., Mestre-Pint\u00f3, J.I., and Domingo-Salvany, A. (2015). Comorbidity of Susbtance Use and Mental Disorders in Europe: A Review of the Data, Publication Office of the European Union. EMCDDA Papers."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Deady, M., Teeson, M., and Brady, K.T. (2013). Impact of substance use on the course of serious mental disorders. Principles of Addiction: Comprehensive Addictive Behaviours and Disorders, Academic Press.","DOI":"10.1016\/B978-0-12-398336-7.00055-3"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s11136-017-1668-4","article-title":"The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain","volume":"26","author":"Daigre","year":"2017","journal-title":"Qual. Life Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09638237.2016.1177771","article-title":"Psychiatric comorbidity and severity of dependence on substance users: How it impacts on their health-related quality of life?","volume":"26","author":"Lozano","year":"2017","journal-title":"J. Ment. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/nsad-2014-0002","article-title":"Co-ocurrence of substance use disorders with other psychiatric disorders: Implications for treatment services","volume":"31","author":"Morisano","year":"2014","journal-title":"Nord. Stud. Alcohol Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000331007","article-title":"Effectiveness of therapeutic communities: A systematic review","volume":"18","author":"Malivert","year":"2012","journal-title":"Eur. Addict. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.15288\/jsad.2013.74.452","article-title":"Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community","volume":"74","author":"Lozano","year":"2013","journal-title":"J. Stud. Alcohol Drugs"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1521-0391.2011.00174.x","article-title":"Personality disorders and retention in a therapeutic community for substance dependence","volume":"20","author":"Samuel","year":"2011","journal-title":"Am. J. Addict."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2011.08.014","article-title":"The impact of borderline personality disorder on residential substance abuse treatment dropout among men","volume":"121","author":"Tull","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.psychres.2019.05.026","article-title":"Psychiatric factors affecting recovery after a long term treatment program for substance use disorder","volume":"276","author":"Daigre","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_11","first-page":"791","article-title":"Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs","volume":"34","author":"Broome","year":"1999","journal-title":"Health Serv. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/15504263.2019.1674465","article-title":"Predictive Outcome Validity of General Health Questionnaire (GHQ-28) in Substance Abuse Patients Treated in Therapeutic Communities","volume":"16","year":"2020","journal-title":"J. Dual Diagn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1465-3362.2011.00298.x","article-title":"Retention, early dropout and treatment completion among therapeutic community admissions","volume":"31","author":"Darke","year":"2012","journal-title":"Drug Alcohol Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12991-016-0119-x","article-title":"The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment","volume":"15","author":"Maremmani","year":"2016","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_15","first-page":"1","article-title":"Predictors of dropout from inpatient substance use treatment: A prospective cohort study","volume":"12","author":"Andersson","year":"2018","journal-title":"Subst. Abus. Res. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108077","DOI":"10.1016\/j.jsat.2020.108077","article-title":"Predictors of premature treatment termination in a large residential addiction medicine program","volume":"117","author":"Syan","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1196\/annals.1441.011","article-title":"Predicting treatment outcome in stimulant dependence","volume":"1141","author":"Reske","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/aje\/kwm355","article-title":"Invited commentary: Variable selection versus shrinkage in the control of multiple confounders","volume":"167","author":"Greenland","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/CLEP.S129886","article-title":"Control of confounding in the analysis phase\u2014An overview for clinicians","volume":"9","author":"Kahlert","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"ref_20","unstructured":"US Food and Drug Administration (2021, April 23). Framework for FDA\u2019s Real World Evidence Program, Available online: https:\/\/www.fda.gov\/media\/120060\/download."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence\u2014What is it and what can it tell us","volume":"375","author":"Sherman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-world evidence and real-world data for evaluating drug safety and effectiveness","volume":"320","author":"Sacks","year":"2018","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurpub\/ckv122","article-title":"The impact of electronic health records on healthcare quality: A systematic review and meta-analysis","volume":"26","author":"Campanella","year":"2016","journal-title":"Eur. J. Public Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijmedinf.2017.04.002","article-title":"Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study","volume":"102","author":"Plantier","year":"2017","journal-title":"Int. J. Med Inform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"108515","DOI":"10.1016\/j.drugalcdep.2021.108515","article-title":"Electronic health record adoption among US substance use disorder and other mental health treatment facilities","volume":"220","author":"Spivak","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsat.2020.02.005","article-title":"The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network","volume":"112","author":"Marsch","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108244","DOI":"10.1016\/j.drugalcdep.2020.108244","article-title":"The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder","volume":"216","author":"Friesen","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2017.02.006","article-title":"The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample","volume":"175","author":"Krawczyk","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/08897077.2018.1545727","article-title":"Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems","volume":"40","author":"Loree","year":"2019","journal-title":"Subst. Abus."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nasir, M., Summerfield, N.S., Oztekin, A., Knight, M., Ackerson, L.K., and Carreiro, S. (2021). Machine learning\u2013based outcome prediction and novel hypotheses generation for substance use disorder treatment. J. Am. Med. Inform. Assoc., 1\u20139.","DOI":"10.1093\/jamia\/ocaa350"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1037\/ser0000333","article-title":"Predicting attrition in long-term residential substance use disorder treatment: A modifiable risk factors perspective","volume":"17","author":"Baker","year":"2020","journal-title":"Psychol. Serv."},{"key":"ref_32","unstructured":"European Monitoring Centre for Drugs and Drug Addiction\u2014EMCDDA (2012). Treatment Demand Indicator (TDI) Standard Protocol 3.0: Guidelines for Reporting Data on People Entering Drug Treatment in European Countries, Publications Office of the European Union."},{"key":"ref_33","unstructured":"Observatorio Espa\u00f1ol de la Droga y las Toxicoman\u00edas\u2014OEDT (2013). Indicador: Admisiones a Tratamiento por Consumo de Sustancais Psicoactivas."},{"key":"ref_34","unstructured":"World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, WHO."},{"key":"ref_35","unstructured":"Arenas, F., del Valle, M., L\u00f3pez, R., Mart\u00edn, J., and Tirado, P. (2003). Programa de Intervenci\u00f3n en Comunidad Terap\u00e9utica en Andaluc\u00eda, Junta de Andaluc\u00eda. Consejer\u00eda de Asuntos Sociales."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","article-title":"Drop-out from addiction treatment: A systematic review of risk factors","volume":"33","author":"Brorson","year":"2013","journal-title":"Clin. Psychol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.013","article-title":"Profiles of substance use disorders in patients of therapeutic communities: Link to social, medical and psychiatric characteristics","volume":"149","author":"Lozano","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsat.2017.01.016","article-title":"One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder","volume":"76","author":"Hagen","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cave, J., and Godfrey, C. (2007). Economics of addiction and drugs. Drugs and the Future, Academic Press.","DOI":"10.1037\/e603332011-001"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/08897077.2013.812544","article-title":"Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine dependent patients in therapeutic communities","volume":"35","author":"Lozano","year":"2014","journal-title":"Subst. Abus."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11469-015-9540-7","article-title":"Personality structure features associated with early dropout in patients with substance-related disorders and comorbid personality disorders","volume":"13","author":"Preti","year":"2015","journal-title":"Int. J. Ment. Health Addict."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/15504263.2020.1829769","article-title":"Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review","volume":"17","author":"Lozano","year":"2021","journal-title":"J. Dual Diagn."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"110298","DOI":"10.1016\/j.pnpbp.2021.110298","article-title":"Do comorbid personality disorders in cocaine dependence exacerbate neuroanatomical alterations? A structural neuroimaging study","volume":"110","author":"Roberts","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neubiorev.2016.09.030","article-title":"Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways","volume":"71","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1037\/bul0000101","article-title":"Interpersonal dysfunction in personality disorders: A meta-analytic review","volume":"143","author":"Wilson","year":"2017","journal-title":"Psychol. Bull."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/NMD.0000000000000553","article-title":"Cluster B personality disorder traits as a predictor of therapeutic alliance over time in residential treatment for substance use disorders","volume":"204","author":"Olesek","year":"2016","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10503301003636696","article-title":"Conflict begets conflict: Executive control, mental state vacillations, and the therapeutic alliance in treatment of borderline personality disorder","volume":"20","author":"Levy","year":"2010","journal-title":"Psychother. Res."},{"key":"ref_48","first-page":"66","article-title":"Dual diagnosis in depression: Treatment recommendations","volume":"30","author":"Szerman","year":"2018","journal-title":"Adicciones"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/15504263.2017.1349977","article-title":"The Concept of Recovery as Experienced by Persons with Dual Diagnosis: A Systematic Review of Qualitative Research From a First-Person Perspective","volume":"13","author":"Vandevelde","year":"2017","journal-title":"J. Dual Diagn."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10488-012-0449-1","article-title":"Dual diagnosis capability in mental health and addiction treatment services: An assessment of programs across multiple state systems","volume":"41","author":"McGovern","year":"2014","journal-title":"Adm. Policy Ment. Health"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.comppsych.2014.11.021","article-title":"Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: Findings from the \u201cPsychiatric and Addictive Dual Disorder in Italy (PADDI)\u201d study","volume":"58","author":"Crocamo","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Schulte, S.J., Meier, P., and Stirling, J. (2011). Dual diagnosis clients\u2019 treatment satisfaction\u2014A systematic review. BMC Psychiatry, 11.","DOI":"10.1186\/1471-244X-11-64"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/12\/2572\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:56Z","timestamp":1760163176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/12\/2572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jcm10122572"],"URL":"https:\/\/doi.org\/10.3390\/jcm10122572","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}